ARLINGTON, VA / ACCESSWIRE / October 11, 2016 / MGC Diagnostics Corporation (NASDAQ:MGCD) will be presenting at this year's The MicroCap Conference on October 24-25 in Philadelphia at the Hotel Monaco, along with 60 other companies in the microcap universe.
The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and mingle with other microcap investors.
This event is free for private and institutional investors - to learn more, please click here.
About MGC Diagnostics Corporation
MGC Diagnostics® and Medisoft are global medical technology companies dedicated to cardiorespiratory health solutions. Since 1977, we have been developing, manufacturing and marketing non-invasive diagnostic systems for the detection, classification and management of cardiorespiratory disease.
SOURCE: MGC Diagnostics Corporation
ReleaseID: 446878
